• SENSEX 76,738.17
    585.31 (+0.77%)
  • BANKNIFTY 57,380.60
    208.60 (+0.36%)
  • Gland Pharma
    2,826.60 1,575.00(%)
  • Tata Technolog.
    830.10 890.15(%)
  • IFCI
    103.95 101.60(%)
  • HFCL
    231.40 257.00(%)
  • Lumino Inds
    122.00 119.00(%)
  • Jindal Worldwide
    57.06 47.55(%)
  • Netweb Technol.
    5,424.00 5,810.00(%)
  • Angel One
    308.20 360.20(%)
  • HBL Engineering
    723.85 1,121.95(%)
  • Multi Comm. Exc.
    3,257.00 3,479.80(%)
  • Adani Total Gas
    620.85 859.70(%)
  • Lenskart Solut.
    694.75 680.95(%)
  • Oberoi Realty
    1,932.25 1,985.00(%)
  • RBL Bank
    413.50 410.45(%)
  • Tejas Networks
    613.50 644.75(%)
  • Polycab India
    8,308.55 6,660.50(%)
  • Antelopus Selan
    986.05 357.00(%)
  • Nuvoco Vistas
    353.50 477.35(%)
  • One 97
    1,691.50 1,732.00(%)
  • Reliance Industries
    1,332.30 1,611.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kimia Biosciences Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4940.0
  • ISIN : INE285U01025
28.50 0 (-1.11%)
  • As on 04 Sep 2026 (EOD)

  • Today’s Low

    28.50

  • Today’s High

    28.96

  • Open

    28.96

  • Perv Close

    28.82

  • 52W Low

    23.20

  • 52W High

    43.28

Key Indicators

  • P/E(TTM)

    18.75

  • Mar.Cap (₹Cr.)

    134.84

  • Div & Yield %

    0.00

  • Book Value(₹)

    3.75

  • Debt-Equity Ratio

    -1.11

  • AGM Date

    03-Sep-2026

  • EPS

    1.52

  • P/E Ratio

    18.75

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    134.84

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    4.73

  • BV (₹)

    3.70

  • Sales( ₹ in Cr.)

    114.88

  • NP (in Cr.)

    7.43

  • NP Var(%)

    -23.0

  • Div%

    0.0

  • CPS (₹)

    2.40

  • EPS (₹)

    1.60

  • Traded Value (₹ in Lakhs)

    134.84

  • 52 Week High

    43.28

  • 52 Week Low

    23.20

  • Price BSE

    29.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    134.84

  • P/C Ratio

    12.10

  • P/E Ratio

    18.50

  • Price Vs.BV

    1.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 118.92 104.88 128.52 124.90 132.71 106.29
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 118.92 104.88 128.52 124.90 132.71 106.29
Other Income 1.32 1.64 1.21 0.93 2.46 0.96
Stock Adjustments 3.68 -7.90 10.36 3.77 6.27 -1.15
Total Income 123.92 98.62 140.09 129.60 141.44 106.10
EXPENDITURE :            
Raw Materials 74.55 67.36 106.39 96.03 103.13 79.09
Power and Fuel Cost 5.66 5.25 7.29 6.54 4.54 3.21
Employee Cost 13.68 15.15 16.40 15.08 14.09 10.80
Other Manufacturing Expenses 1.61 1.93 2.93 2.40 2.64 1.74
Selling and Administration Expenses 6.67 7.22 7.04 6.16 4.88 3.76
Miscellaneous Expenses 0.19 0.55 4.85 1.82 1.33 2.08
Employee Benefit Expenses 13.68 15.15 16.40 15.08 14.09 10.80
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 102.35 97.46 144.90 128.04 130.61 100.68
Operating Profit 21.57 1.16 -4.81 1.56 10.84 5.42
Interest 4.56 5.05 4.25 3.64 3.39 2.53
Gross Profit 17.01 -3.89 -9.06 -2.08 7.45 2.89
Depreciation 3.38 3.29 3.33 2.94 1.91 1.66
Profit Before Tax 13.63 -7.18 -12.39 -5.02 5.54 1.23
Current Tax 0.00 0.00 0.00 0.00 0.00 -0.16
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.02 -1.88 -3.04 -1.32 0.43 0.00
Reported Net Profit 9.61 -5.31 -9.35 -3.70 5.10 1.38
Extraordinary Items 0.00 0.00 -1.05 0.08 0.07 -0.01
Adjusted Net Profit 9.61 -5.31 -8.30 -3.78 5.03 1.39
Adjustment below Net Profit 0.02 0.18 -0.07 0.16 -0.04 0.00
P & L Balance brought forward -10.49 -5.35 4.07 7.62 2.56 1.23
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -0.85 -10.49 -5.35 4.07 7.62 2.61
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.03 -1.12 -1.98 -0.78 1.08 0.30
Earnings Per Share(Adj)-Unit Curr 2.03 -1.12 -1.98 -0.78 1.08 0.30
Book Value 2.11 0.07 1.15 3.15 3.90 2.86
Book Value(Adj)-Unit Curr 2.11 0.07 1.15 3.15 3.90 2.86

Shareholding Pattern

  • Promoter Group

    74.94%

  • Public Share Holding

    25.06%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 35,455,808 74.94 35,455,808 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 35,455,808 74.94 35,455,808 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 181,100 0.38 181,100 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 181,100 0.38 181,100 3
2] Non Institution
Bodies Corporate 110,018 0.23 110,018 41
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 567,351 1.20 567,351 197
Foreign Non Institution Other 100,000 0.21 100,000 1
Hindu Undivided Families 73,599 0.16 73,599 61
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,577,978 16.02 7,577,978 4
Individuals holding nominal share capital up to Rs. 1 lakh 3,246,887 6.86 3,246,887 12,466
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 11,675,833 24.68 11,675,833 12,770
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 47,312,741 100.00 47,312,741 12,775

Company Background

Kimia Biosciences LtdPharmaceuticals - Indian - Bulk Drugs

  • Kimia Biosciences Ltd
  • BSE Code : 4940.0
  • ISIN : INE285U01025

  • Incorporation Year

    1993

  • Registered Office

    Bhondsi Village
    Tehsil Sohna, Gurgaon,
    Haryana-122102

  • Telephone

    91-11-29535650

  • FAX

  • Chairman

    Sameer Goel

  • Managing Director

  • Company Secretary

  • Auditor

    Neeraj Arora & Associates

  • Face Value

    1

  • Listing

    BSE

  • Registrar

    Beetal Fin.&Computer Ser.P Ltd
    99 BeetalHouse 3rd F,
    Behind Local Shp Cen,Nr Dada Harsukh Das
    Mumbai - New Delhi - 110062

Kimia Biosciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kimia Bioscien. 28.50 120.24 118.92 18.75 34.57
Abbott India 25,878.50 7,217.19 6,929.05 34.06 43.78
Astrazeneca Phar 6,946.95 2,304.07 2,275.58 102.39 27.86
Glaxosmi. Pharma 2,935.35 3,932.76 3,790.20 46.89 58.17
Novartis India 1,614.95 398.23 356.27 40.78 16.64
Cipla 1,389.00 20,102.60 18,979.95 36.50 13.88
Bliss GVS Pharma 636.90 773.53 729.81 59.14 12.51
Amrutanjan Healt 507.20 520.13 502.55 27.17 24.16
Fermenta Biotec. 502.80 474.15 450.25 23.47 18.77
Guj. Themis Bio. 425.00 152.47 150.80 113.64 27.21
Ambalal Sarabhai 43.88 19.52 3.94 81.26 6.77